相关实验视频

Updated: Mar 14, 2026

Author Spotlight: Accelerating Research on Bacterial Extracellular Vesicles Separation and Heterogeneity

Author Spotlight: Accelerating Research on Bacterial Extracellular Vesicles Separation and Heterogeneity

Published on: September 1, 2023

在接受胃旁路手术的肥胖患者中,肠道微生物群衍生的细胞外囊

Jenni Hekkala^1,2, Anna Kaisanlahti^1,2, Mysore V Tejesvi^2,3

¹Research Unit of Translational Medicine, University of Oulu, Oulu, Finland.

Molecular microbiology

|March 13, 2026

概括

在肥胖患者中,Roux-en-Y胃绕道手术显著改变了肠道微生物群及其细胞外囊 (EVs). 这些EV可能会影响减肥手术.

科学领域:

微生物组研究微生物组研究
腹部外科手术的结果
细胞外囊泡生物学细胞外囊泡生物学

背景情况:

人的肠道微生物群在肥胖中起着至关重要的作用.
由肠道微生物群衍生的细胞外囊泡 (EVs) 正在成为宿主-微生物通信的关键媒介.
减肥手术对这些EVs的影响在很大程度上仍未被探索.

研究的目的:

为了研究Roux-en-Y胃绕道 (RYGB) 对肠道微生物群组成的影响.
在肥胖患者中,在RYGB之后,对肠道微生物群衍生的EVs的变化进行表征.
探索EVs在减肥手术对健康的影响中的潜在作用.

主要方法:

在基线和RYGB后6个月内从30名肥胖患者收集了便样本.
用16S rRNA基因测序分析了肠道微生物组成.
分离了细胞外囊泡 (EVs),并分析了它们的蛋白质含量.

主要成果:

RYGB显著改变了肠道微生物群组成 (p=0.001) 和肠道微生物群衍生的EVs的特征 (p=0.001).
在EV中发现的独特蛋白质的数量在手术后增加.
一个随机的森林分类器准确地区分了微生物群 (AUC=0.93) 和EVs (AUC=0.80) 的手术前和手术后状态.

结论:

在肥胖个体中,胃绕道手术诱导了肠道微生物群及其分泌的EV的显著变化.
由肠道微生物群衍生出的EVs代表了一个潜在的机制,通过这种机制,减肥手术可以发挥其全身健康效应.
对电动汽车的进一步研究可能会揭示肥胖和相关代谢障碍的新疗法标.

关键词:

细胞外囊泡中的细胞外囊泡.胃绕道手术是什么意思我们的肠道微生物群.纳米颗粒是一种纳米粒子.肥胖肥胖肥胖肥胖肥胖肥胖肥胖肥胖

更多相关视频

Roux-en-Y Gastric Bypass Operation in Rats

Roux-en-Y Gastric Bypass Operation in Rats

Published on: June 11, 2012

Sleeve Gastrectomy in Mice using Surgical Clips

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

相关概念视频

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

Gastric Emptying

Gastric Emptying

Gastric emptying occurs when the stomach gradually releases chyme into the duodenum. When the stomach is distended, it triggers the release of gastrin, a hormone that promotes gastric acid secretion to aid in digestion. Additionally, stomach distension contributes to peristaltic waves that propel gastric contents toward the pyloric region. The gastroenteric reflex, on the other hand, primarily stimulates peristalsis in the intestines, facilitating the movement of contents further along the...

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...